Literature DB >> 16877414

A new locus for autosomal dominant cataract on chromosome 19: linkage analyses and screening of candidate genes.

J Bronwyn Bateman1, Leslie Richter, Pamela Flodman, Douglas Burch, Sandra Brown, Philip Penrose, Otis Paul, David D Geyer, David G Brooks, M Anne Spence.   

Abstract

PURPOSE: To map and identify the mutated gene for autosomal dominant cataract (ADC) in family ADC4.
METHODS: Ophthalmic evaluations were performed on an American family with ADC and a panel of polymorphic DNA sequence-tagged site (STS) markers for known ADC loci and other genome-wide polymorphic markers were used to map the gene; two-point lod scores were calculated. Fine mapping was undertaken in the chromosomal regions of maximum lod scores, and candidate genes were sequenced.
RESULTS: A four-generation American family with ADC was studied. The only phakic individual exhibited white and vacuolated opacities in the cortical region. This ADC locus mapped to several suggestive chromosomal regions. Assuming full penetrance, the highest calculated maximum lod score was 3.91 with D19S903 [corrected] On chromosome 12, we sequenced all exons and the exon-intron borders of the membrane intrinsic protein (MIP) gene. On chromosome 19, all exons and the exon-intron borders of genes for lens intrinsic membrane2 (LIM2), ferritin light chain (FTL), and the human homologue of the Drosophila sine oculis homeobox 5 (SIX5) were sequenced, and the 3' untranslated repeat region (UTR) of the dystrophy (DMPK) gene and both the 5' and 3' UTRs of the SIX5 genes were amplified; the promoter for LIM2 was sequenced. For these genes, the sequence matched that in the reference libraries, and the DMPK gene had a normal number of CTG repeats.
CONCLUSIONS: The mutated gene in ADC4 probably represents a new, not yet identified locus on chromosome 19. In one phakic member, the cortical cataracts were punctate and vacuolated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877414     DOI: 10.1167/iovs.05-1035

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  SIPA1L3 identified by linkage analysis and whole-exome sequencing as a novel gene for autosomal recessive congenital cataract.

Authors:  Christina Evers; Nagarajan Paramasivam; Katrin Hinderhofer; Christine Fischer; Martin Granzow; Annette Schmidt-Bacher; Roland Eils; Herbert Steinbeisser; Matthias Schlesner; Ute Moog
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

2.  iSyTE: integrated Systems Tool for Eye gene discovery.

Authors:  Salil A Lachke; Joshua W K Ho; Gregory V Kryukov; Daniel J O'Connell; Anton Aboukhalil; Martha L Bulyk; Peter J Park; Richard L Maas
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-21       Impact factor: 4.799

Review 3.  The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease.

Authors:  J P Kumar
Journal:  Cell Mol Life Sci       Date:  2009-02       Impact factor: 9.261

Review 4.  Cat-Map: putting cataract on the map.

Authors:  Alan Shiels; Thomas M Bennett; J Fielding Hejtmancik
Journal:  Mol Vis       Date:  2010-10-08       Impact factor: 2.367

Review 5.  Congenital cataracts and their molecular genetics.

Authors:  J Fielding Hejtmancik
Journal:  Semin Cell Dev Biol       Date:  2007-10-10       Impact factor: 7.727

6.  An autosomal dominant cataract locus mapped to 19q13-qter in a Chinese family.

Authors:  Rui Zhao; Yonjia Yang; Xinyu He; Zheng Liu; Pin Wang; Lijun Zhou; Jinsong Tang; Wei Xu; Liping Li; Yimin Zhu
Journal:  Mol Vis       Date:  2011-01-25       Impact factor: 2.367

7.  Combinational analysis of linkage and exome sequencing identifies the causative mutation in a Chinese family with congenital cataract.

Authors:  Xueyuan Jia; Feng Zhang; Jing Bai; Linghan Gao; Xuelong Zhang; Haiming Sun; Donglin Sun; Rongwei Guan; Wenjing Sun; Lidan Xu; Zhichao Yue; Yang Yu; Songbin Fu
Journal:  BMC Med Genet       Date:  2013-10-08       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.